Levocetirizine + Montelukast
Composition
The formulation contains Levocitrazine, Montelukast as the active ingredient.
Indications
Indicated for the treatment of allergic rhinitis and asthma.
Side effects
Side effects may include drowsiness, headache, and gastrointestinal disturbances.
Precautions
caution when driving or operating machinery due to potential drowsiness.
Contraindications
Contraindicated in patients with severe renal impairment, phenylketonuria (for formulations containing aspartame).
Dosage and administration
As directed by the physician
Countries
Worldwide
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai